Jump to Main Content
- Kass, P.H., et al. Show all 7 Authors
- Veterinary and comparative oncology 2006 v.4 no.3 pp. 132-140
- dogs; brain; neoplasms; messenger RNA; gene expression; growth factors; receptors; protein kinases; dog diseases; veterinary medicine
- ... Inhibition of tumour growth and angiogenesis by targeting key growth factor receptors is a promising therapeutic strategy for central nervous system tumours. Characterization of these growth factor receptors in canine primary brain tumours has not been done. Using quantitative real-time TaqMan polymerase chain reaction (PCR), we evaluated the expression of messenger RNA (mRNA) for five tyrosine ki ...
- Kass, P.H., et al. Show all 6 Authors
- Journal of veterinary pharmacology and therapeutics 2005 v.28 no.6 pp. 505-513
- intravenous injection; parrots; dosage; animal models; Coturnix japonica; oxytetracycline; pharmacokinetics
- ... The purpose of this study was to determine whether Japanese quail (Coturnix japonica) would serve as a pharmacokinetic animal model for two small companion parrots: cockatiels (Nymphicus hollandicus) and Poicephalus parrots. Oxytetracycline (OTC) was the pharmacologic agent chosen for this study as it is eliminated primarily by renal glomerular filtration and undergoes minimal metabolism. A single ...